Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 14, Issue 9, 1999, Pages 2178-2183

  Marchais, Sylvain J ^a   Metivier, Fabien ^a   Guerin, Alain P ^a   London, Gérard M ^a  

^a Hopital Manhes   (France)

Author keywords

Arteriosclerosis; Cardiac output; Cardiac work; End stage renal disease; Hyperphosphataemia; Hypertension

Indexed keywords

PHOSPHATE;

ADULT; ARTERY DIAMETER; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; HEART FUNCTION; HEART INDEX; HEART RATE; HEART STROKE VOLUME; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; BLOOD CIRCULATION; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CAROTID ARTERIES; ECHOCARDIOGRAPHY; FEMALE; HEART; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHATES; REGRESSION ANALYSIS; VASOCONSTRICTION;

EID: 0032780460     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.9.2178     Document Type: Article

References (25)

1. Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7[Suppl. 2]: 7-35
2. USRDS. US Renal Data System Annual Report, Bethesda, MD, The National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 1998; 32 [Suppl. 1]: S81-88
3. Lindner A, Charra B, Sherrard D, Scribner BM. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-702
4. London GM, Guérin AP, Marchais SJ et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608
5. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
6. Bogin E, Massry SG, Harary I. Effect of parathyroid hormone on heart cells. J Clin Invest 1981; 67: 1215-1227
7. Katho Y, Klein KL, Kaplan RA, Sanborn WG, Kurokawa K. Parathyroid hormone has a positive inotropic action in the rat. Endocrinology 1981; 109: 2252-2254
8. Lhoste F, Drüeke T, Larus S, Boissier JR. Cardiac interaction between parathyroid hormone, β-adrenoreceptor, and Verapamil in the guinea pig in vitro. Clin Exp Pharmacol Physiol 1980; 7: 377-382
9. London GM, De Vernejoul M-Ch, Fabiani F et al. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 1987; 32: 900-907
10. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 1978; 58: 1072-1083
11. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-18
12. London GM, Marchais SJ, Guérin AP et al. Salt and water retention and calcium blockade in uremia. Circulation 1990; 82: 105-113
13. Kelly R, Daley J, Avolio A, O'Rourke M. Arterial dilation and reduced wave reflection: Beneficial effects of Dilevalol in essential hypertension. Hypertension 1989; 14: 14-21
14. Hoeks APG, Brands PJ, Smeets FA, Reneman RS. Assessment of distensibility of superficial arteries. Ultrasound Med Biol 1990; 16: 121-128
15. Touboul PJ, Prati P, Scarabin PY et al. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens 1992; 10 [Suppl 5]: S37-S41
16. Demuth K, Blacher J, Guérin AP et al. Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant 1998; 13: 375-383
17. Port FK. Fluid and electrolyte disorders in dialysis. In: Kokko JP and Tannen RL (eds). Fluids and Electrolytes (2nd Edition), WB Saunders Company, Philadelphia: 1990: 747-780
18. London G, Marchais S, Guérin A. Blood pressure control in chronic hemodialysis patients. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds). Replacement of Renal Function by Dialysis, (4th Edition), Kluwer Academic Publishers, Dordrecht: 1996: 966-989
19. Hino T, Hyby ND, Fittingoff M, Tuck ML, Brickman AS. Parathyroid hormone analogues inhibit calcium mobilization in cultured vascular cells. Hypertension 1994; 23: 402-408
20. Hanson AS, Linas SL. Parathyroid hormone/adenylate cyclase coupling in vascular smooth muscle cells. Hypertension 1994; 23: 468-475
21. Gafter U, Battler A, Eldar M, Zevin D, Neufeld HN, Levi J. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. Nephron 1981; 41: 30-33
22. Zucchelli P, Santoro A, Zucchelli M, Spongano M, Ferrari G. Long-term effects of parathyroidectomy on cardiac and autonomic nervous system functions in hemodialysis patients. Nephrol Dial Transplant 1988; 3: 45-50
23. Fellner SK, Lang RM, Neumann A, Bushinsky DA, Borow KM. Parathyroid hormone and myocardial performance in dialysis patients. Am J Kidney Dis 1991; 18: 320-325
24. Girerd X, London G, Boutouyrie P, Mourad JJ, Laurent S, Safar M. Remodelling of radial artery and chronic increase in shear stress. Hypertension 1996; 27[part 2]: 799-803
25. Amann K, Wiest G, Klaus G, Ritz E, Mall G. The role of parathyroid hormone in the genesis of interstitial cell activation in uremia. J Am Soc Nephrol 1994; 4: 1814-1819